Literature DB >> 33283554

Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals.

Milena Cavic1, Ana Krivokuca1, Ivana Boljevic1, Jelena Spasic2, Milica Mihajlovic1, Marijana Pavlovic1, Ana Damjanovic1, Davorin Radosavljevic2, Radmila Jankovic1.   

Abstract

Background: The SARS-CoV-2 pandemic introduced a global distraction effect in all aspects of cancer patients' care. The aim of this study was to explore the effect of the pandemic on the largest molecular diagnostics center for cancer patients and high-risk individuals in Serbia. Research design and methods: EGFR, KRAS/NRAS, BRAF and BRCA1/2 mutation testing were performed by qPCR and NGS. NGS was used for panel testing of hereditary breast/ovarian cancer and cancers associated with Lynch syndrome. The analytical output during the state of emergency (SoE) was compared to the period before and after the outbreak using one-way ANOVA. Statistical significance was set at p<0.05.
Results: A 38% reduction in the number of analysis was detected during the SoE. After the SoE, a 19% reduction was noted compared to SoE and 50% compared to the period before the SoE (p=0.038). Only 3 of the 48 scheduled appointments for pre-test genetic counseling were carried out during the SoE, but the number of NGS tests increased by 50%. Conclusions: The SARS-CoV-2 pandemic had a profound negative effect on the diagnostic output of our centralized molecular diagnostics center. The only positive effect was shortening of waiting lists for hereditary cancer patients and high-risk individuals.

Entities:  

Keywords:  SARS-CoV-2; cancer genetics; companion diagnostics; genetic counseling; hereditary cancer

Year:  2020        PMID: 33283554     DOI: 10.1080/14737159.2021.1860760

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  6 in total

1.  Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Authors:  Jelena Spasic; Milena Cavic; Nemanja Stanic; Bojan Zaric; Tomi Kovacevic; Davorin Radosavljevic; Ljudmila Nagorni-Obradovic
Journal:  Dose Response       Date:  2022-06-28       Impact factor: 2.623

Review 2.  Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease.

Authors:  Estefanía Moreno; Milena Cavic; Enric I Canela
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

3.  Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.

Authors:  Rudolf M Huber; Milena Cavic; Anna Kerpel-Fronius; Lucia Viola; John Field; Long Jiang; Ella A Kazerooni; Coenraad F N Koegelenberg; Anant Mohan; Ricardo Sales Dos Santos; Luigi Ventura; Murry Wynes; Dawei Yang; Javier Zulueta; Choon-Taek Lee; Martin C Tammemägi; Claudia I Henschke; Stephen Lam
Journal:  J Thorac Oncol       Date:  2021-12-03       Impact factor: 15.609

4.  Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.

Authors:  Vera Jokic; Katarina Savic-Vujovic; Jelena Spasic; Zoran Bukumiric; Mladen Marinkovic; Davorin Radosavljevic; Milena Cavic
Journal:  Dose Response       Date:  2022-08-04       Impact factor: 2.623

Review 5.  The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients.

Authors:  María José Domper-Arnal; Gonzalo Hijos-Mallada; Ángel Lanas
Journal:  Therap Adv Gastroenterol       Date:  2022-08-22       Impact factor: 4.802

Review 6.  Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.

Authors:  Jonathan Kopel; Bojana Ristic; Gregory L Brower; Hemant Goyal
Journal:  Medicina (Kaunas)       Date:  2022-01-10       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.